- Home
- PKG vs BAX Comparison
PKG vs BAX Comparison
Compare PKG & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKG
- BAX
- Stock Information
- Founded
- PKG 1867
- BAX 1931
- Country
- PKG United States
- BAX United States
- Employees
- PKG N/A
- BAX N/A
- Industry
- PKG Containers/Packaging
- BAX Medical/Dental Instruments
- Sector
- PKG Consumer Discretionary
- BAX Health Care
- Exchange
- PKG Nasdaq
- BAX Nasdaq
- Market Cap
- PKG 17.5B
- BAX 15.6B
- IPO Year
- PKG 2000
- BAX N/A
- Fundamental
- Price
- PKG $190.47
- BAX $30.49
- Analyst Decision
- PKG Strong Buy
- BAX Buy
- Analyst Count
- PKG 6
- BAX 8
- Target Price
- PKG $230.33
- BAX $37.25
- AVG Volume (30 Days)
- PKG 785.0K
- BAX 3.5M
- Earning Date
- PKG 07-22-2025
- BAX 05-01-2025
- Dividend Yield
- PKG 2.59%
- BAX 2.23%
- EPS Growth
- PKG 19.48
- BAX N/A
- EPS
- PKG 9.56
- BAX N/A
- Revenue
- PKG $8,544,799,999.00
- BAX $10,771,000,000.00
- Revenue This Year
- PKG $6.58
- BAX $8.06
- Revenue Next Year
- PKG $3.45
- BAX $4.19
- P/E Ratio
- PKG $20.21
- BAX N/A
- Revenue Growth
- PKG 9.47
- BAX 15.36
- 52 Week Low
- PKG $172.72
- BAX $26.25
- 52 Week High
- PKG $250.82
- BAX $40.49
- Technical
- Relative Strength Index (RSI)
- PKG 54.70
- BAX 47.96
- Support Level
- PKG $191.63
- BAX $29.72
- Resistance Level
- PKG $194.65
- BAX $31.04
- Average True Range (ATR)
- PKG 3.39
- BAX 0.72
- MACD
- PKG 0.55
- BAX -0.03
- Stochastic Oscillator
- PKG 82.91
- BAX 26.01
About PKG Packaging Corporation of America
Packaging Corp. of America is the third-largest containerboard and corrugated packaging manufacturer in the United States. It produces over 5 million tons of containerboard annually. The company's share of the domestic containerboard market is roughly 10%. PCA differentiates itself from larger competitors by focusing on smaller customers and operating with a high degree of flexibility.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.